SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-11-001209
Filing Date
2011-04-29
Accepted
2011-04-29 15:11:18
Documents
3
Period of Report
2011-06-06
Effectiveness Date
2011-04-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_042911.htm DEF 14A 490824
2 holliman.gif GRAPHIC 3021
3 logo.gif GRAPHIC 6537
  Complete submission text file 0001171843-11-001209.txt   505378
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33560 | Film No.: 11793946
SIC: 2834 Pharmaceutical Preparations